Skip to main content

Table 1 (abstract P146). See text for description

From: Proceedings of the 28th European Paediatric Rheumatology Congress (PReS 2022)

FAMILY

PATIENT

GENDER

AGE

ONSET

COURSE

CLINICAL MANIFESTATIONS

LABORATORY FINDINGS

PREVIOUS DIAGNOSES

TREATMENTS

1

1

F

62y

early childhood

relapsing-remitting

rA, HD, AA, PS

CRP/ESR ↑, ANA/ENA +, IFN-score -

HD, PA, RA, SS, SLE

steroids > adalimumab > tofacitinib

2

F

32y

early childhood

relapsing-remitting

rA, rF, rI, CD, HD, AA, SK, PS, AH

CRP/ESR ↑, ANA/ENA -, IFN-score +

CD, AH, HD

steroids > azathioprine

3

M

10y

<1y

relapsing-remitting

rA, CD

CRP/ESR ↑, IFN-score +

none

steroids > colchicine

4

M

8y

<1y

relapsing-remitting

rA, rF, rI, GI, PS

CRP/ESR ↑,

IFN-score +

PFAPA, IBD, BD

steroids > adalimumab

5

F

1y

<1y

relapsing-remitting

rA, rF, rI

CRP/ESR ↑, IFN-score +

none

steroids

2

6

M

22y

<1y

relapsing-remitting

rA, rF, rI, GI, AA, PS

CRP/ESR ↑, ANA/ENA -, IFN-score +

PFAPA, IBD, BD

steroids > adalimumab > apremilast

3

7

F

2y

<1y

relapsing-remitting

rA, GI, AA, SK

CRP/ESR ↑, IFN-score +

IBD

steroids > anakinra > infliximab + methotrexate

  1. F, female; M, male; y, years; rA, recurrent aphthous; rF, recurrent fever; rI, recurrent infections; GI, gastrointestinal symptoms; CD, celiac disease; HD, Hashimoto’s disease; AA, arthritis/arthralgia; SK, skin involvement; PS, psychiatric complaints; AH, autoimmune hepatitis; PA, psoriatic arthritis; RA, rheumatoid arthritis; SS, Sjogren syndrome; BD, Behçet’s disease